- £18.86m
- £17.75m
- £6.53m
Contract Win
Contract Win
Contract Win
Brief: IXICO Reports HY Revenue Of £2.5 Million
Half-year Report
Notice of half year results
Life Molecular Imaging – Neuraceq Supply Agreement
Imeka Collaboration Agreement
Imeka Collaboration Agreement
Brief: IXICO Sees FY 2024 Revenues Of 5.2 Mln Stg To 5.9 Mln Stg
Trading Update
Holding(s) in Company
Brief: Ixico Says Giulio Cerroni To Retire As Chief Executive Officer
Directorate Change
Update regarding Nominated Adviser and Broker
Brief: Ixico Says Charles Spicer To Retire From Board At AGM On 25 Jan 2024
Financial Results for year ended 30 September 2023
Notice of Results and Investor Presentation
Appointment of Independent Non-Executive Director